Angiogenic Effects of Collagen/Mesoporous Nanoparticle Composite Scaffold Delivering VEGF165

Vascularization is a key issue for the success of tissue engineering to repair damaged tissue. In this study, we report a composite scaffold delivering angiogenic factor for this purpose. Vascular endothelial growth factor (VEGF) was loaded on mesoporous silica nanoparticle (MSN), which was then inc...

Full description

Bibliographic Details
Main Authors: Joong-Hyun Kim, Tae-Hyun Kim, Min Sil Kang, Hae-Won Kim
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2016/9676934
id doaj-1b6e936fe10249b1ac8f9149f1c0a911
record_format Article
spelling doaj-1b6e936fe10249b1ac8f9149f1c0a9112020-11-24T23:25:24ZengHindawi LimitedBioMed Research International2314-61332314-61412016-01-01201610.1155/2016/96769349676934Angiogenic Effects of Collagen/Mesoporous Nanoparticle Composite Scaffold Delivering VEGF165Joong-Hyun Kim0Tae-Hyun Kim1Min Sil Kang2Hae-Won Kim3Institute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, Republic of KoreaInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, Republic of KoreaInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, Republic of KoreaInstitute of Tissue Regeneration Engineering (ITREN), Dankook University, Cheonan, Republic of KoreaVascularization is a key issue for the success of tissue engineering to repair damaged tissue. In this study, we report a composite scaffold delivering angiogenic factor for this purpose. Vascular endothelial growth factor (VEGF) was loaded on mesoporous silica nanoparticle (MSN), which was then incorporated within a type I collagen sponge, to produce collagen/MSN/VEGF (CMV) scaffold. The CMV composite scaffold could release VEGF sustainably over the test period of 28 days. The release of VEGF improved the cell proliferation. Moreover, the in vivo angiogenesis of the scaffold, as studied by the chick chorioallantoic membrane (CAM) model, showed that the VEGF-releasing scaffold induced significantly increased number of blood vessel complexes when compared with VEGF-free scaffold. The composite scaffold showed good biocompatibility, as examined in rat subcutaneous tissue. These results demonstrate that the CMV scaffold with VEGF-releasing capacity can be potentially used to stimulate angiogenesis and tissue repair.http://dx.doi.org/10.1155/2016/9676934
collection DOAJ
language English
format Article
sources DOAJ
author Joong-Hyun Kim
Tae-Hyun Kim
Min Sil Kang
Hae-Won Kim
spellingShingle Joong-Hyun Kim
Tae-Hyun Kim
Min Sil Kang
Hae-Won Kim
Angiogenic Effects of Collagen/Mesoporous Nanoparticle Composite Scaffold Delivering VEGF165
BioMed Research International
author_facet Joong-Hyun Kim
Tae-Hyun Kim
Min Sil Kang
Hae-Won Kim
author_sort Joong-Hyun Kim
title Angiogenic Effects of Collagen/Mesoporous Nanoparticle Composite Scaffold Delivering VEGF165
title_short Angiogenic Effects of Collagen/Mesoporous Nanoparticle Composite Scaffold Delivering VEGF165
title_full Angiogenic Effects of Collagen/Mesoporous Nanoparticle Composite Scaffold Delivering VEGF165
title_fullStr Angiogenic Effects of Collagen/Mesoporous Nanoparticle Composite Scaffold Delivering VEGF165
title_full_unstemmed Angiogenic Effects of Collagen/Mesoporous Nanoparticle Composite Scaffold Delivering VEGF165
title_sort angiogenic effects of collagen/mesoporous nanoparticle composite scaffold delivering vegf165
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2016-01-01
description Vascularization is a key issue for the success of tissue engineering to repair damaged tissue. In this study, we report a composite scaffold delivering angiogenic factor for this purpose. Vascular endothelial growth factor (VEGF) was loaded on mesoporous silica nanoparticle (MSN), which was then incorporated within a type I collagen sponge, to produce collagen/MSN/VEGF (CMV) scaffold. The CMV composite scaffold could release VEGF sustainably over the test period of 28 days. The release of VEGF improved the cell proliferation. Moreover, the in vivo angiogenesis of the scaffold, as studied by the chick chorioallantoic membrane (CAM) model, showed that the VEGF-releasing scaffold induced significantly increased number of blood vessel complexes when compared with VEGF-free scaffold. The composite scaffold showed good biocompatibility, as examined in rat subcutaneous tissue. These results demonstrate that the CMV scaffold with VEGF-releasing capacity can be potentially used to stimulate angiogenesis and tissue repair.
url http://dx.doi.org/10.1155/2016/9676934
work_keys_str_mv AT joonghyunkim angiogeniceffectsofcollagenmesoporousnanoparticlecompositescaffolddeliveringvegf165
AT taehyunkim angiogeniceffectsofcollagenmesoporousnanoparticlecompositescaffolddeliveringvegf165
AT minsilkang angiogeniceffectsofcollagenmesoporousnanoparticlecompositescaffolddeliveringvegf165
AT haewonkim angiogeniceffectsofcollagenmesoporousnanoparticlecompositescaffolddeliveringvegf165
_version_ 1725557701604278272